ARS Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.38M | Hold |
2,750
| – | – | 0.06% | 95 |
|
|
2026
Q1 | $1.35M | Sell |
2,750
-12
| -0.4% | -$6.51K | 0.07% | 87 |
|
|
2025
Q4 | $1.6M | Buy |
2,762
+57
| +2% | +$32.2K | 0.09% | 81 |
|
|
2025
Q3 | $1.31M | Hold |
2,705
| – | – | 0.09% | 89 |
|
|
2025
Q2 | $1.1M | Sell |
2,705
-72
| -3% | -$30.1K | 0.08% | 94 |
|
|
2025
Q1 | $1.44M | Hold |
2,777
| – | – | 0.13% | 74 |
|
|
2024
Q4 | $1.44M | Hold |
2,777
| – | – | 0.13% | 74 |
|
|
2024
Q3 | $1.72M | Sell |
2,777
-26
| -0.9% | -$15.4K | 0.15% | 68 |
|
|
2024
Q2 | $1.55M | Sell |
2,803
-479
| -15% | -$274K | 0.15% | 64 |
|
|
2024
Q1 | $1.91M | Hold |
3,282
| – | – | 0.19% | 60 |
|
|
2023
Q4 | $1.74M | Hold |
3,282
| – | – | 0.19% | 62 |
|
|
2023
Q3 | $1.66M | Hold |
3,282
| – | – | 0.21% | 61 |
|
|
2023
Q2 | $1.71M | Buy |
3,282
+75
| +2% | +$40.5K | 0.2% | 60 |
|
|
2023
Q1 | $1.85M | Buy |
3,207
+125
| +4% | +$70.5K | 0.22% | 60 |
|
|
2022
Q4 | $1.7M | Hold |
3,082
| – | – | 0.23% | 59 |
|
|
2022
Q3 | $1.56M | Sell |
3,082
-155
| -5% | -$86.7K | 0.21% | 63 |
|
|
2022
Q2 | $1.76M | Buy |
3,237
+40
| +1% | +$22K | 0.24% | 59 |
|
|
2022
Q1 | $1.89M | Sell |
3,197
-115
| -3% | -$66.1K | 0.18% | 69 |
|
|
2021
Q4 | $2.21M | Hold |
3,312
| – | – | 0.2% | 65 |
|
|
2021
Q3 | $1.89M | Hold |
3,312
| – | – | 0.19% | 67 |
|
|
2021
Q2 | $1.67M | Buy |
3,312
+87
| +3% | +$41K | 0.17% | 68 |
|
|
2021
Q1 | $1.47M | Buy |
3,225
+3
| +0.1% | +$1.43K | 0.17% | 67 |
|
|
2020
Q4 | $1.5M | Hold |
3,222
| – | – | 0.18% | 64 |
|
|
2020
Q3 | $1.42M | Hold |
3,222
| – | – | 0.22% | 60 |
|
|
2020
Q2 | $1.17M | Hold |
3,222
| – | – | 0.22% | 44 |
|
|
2020
Q1 | $914K | Hold |
3,222
| – | – | 0.22% | 53 |
|
|
2019
Q4 | $1.05M | Hold |
3,222
| – | – | 0.18% | 69 |
|
|
2019
Q3 | $938K | Sell |
3,222
-50
| -2% | -$14.3K | 0.17% | 67 |
|
|
2019
Q2 | $961K | Sell |
3,272
-18
| -0.5% | -$4.96K | 0.16% | 77 |
|
|
2019
Q1 | $901K | Hold |
3,290
| – | – | 0.16% | 77 |
|
|
2018
Q4 | $736K | Sell |
3,290
-21
| -0.6% | -$4.93K | 0.16% | 78 |
|
|
2018
Q3 | $808K | Hold |
3,311
| – | – | 0.13% | 93 |
|
|
2018
Q2 | $686K | Hold |
3,311
| – | – | 0.11% | 93 |
|
|
2018
Q1 | $684K | Hold |
3,311
| – | – | 0.08% | 119 |
|
|
2017
Q4 | $629K | Sell |
3,311
-27
| -0.8% | -$5.17K | 0.08% | 131 |
|
|
2017
Q3 | $632K | Buy |
3,338
+18
| +0.5% | +$3.26K | 0.08% | 124 |
|
|
2017
Q2 | $579K | Hold |
3,320
| – | – | 0.08% | 126 |
|
|
2017
Q1 | $510K | Buy |
3,320
+55
| +2% | +$8.41K | 0.07% | 124 |
|
|
2016
Q4 | $461K | Sell |
3,265
-41,928
| -93% | -$6.18M | 0.07% | 131 |
|
|
2016
Q3 | $7.19M | Sell |
45,193
-268
| -0.6% | -$41.3K | 1.58% | 24 |
|
|
2016
Q2 | $6.72M | Buy |
45,461
+26,155
| +135% | +$3.86M | 1.5% | 29 |
|
|
2016
Q1 | $2.73M | Sell |
19,306
-1,202
| -6% | -$161K | 0.64% | 50 |
|
|
2015
Q4 | $2.91M | Sell |
20,508
-142
| -0.7% | -$18.9K | 0.68% | 50 |
|
|
2015
Q3 | $2.52M | Buy |
20,650
+855
| +4% | +$111K | 0.58% | 54 |
|
|
2015
Q2 | $2.57M | Buy |
19,795
+1,190
| +6% | +$155K | 0.47% | 59 |
|
|
2015
Q1 | $2.5M | Buy |
+18,605
| New | +$2.4M | 0.46% | 57 |
|
Other funds holding TMO
RG
LT
ATO
CF
ARS Investment Partners's TMO Position: Q2 2026 in Review
ARS Investment Partners held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,750 shares worth $1.38M. The position accounts for 0.06% of the portfolio, ranked #95.
ARS Investment Partners first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.19M in Q3 2016. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- ARS Investment Partners held 2,750 shares of Thermo Fisher Scientific worth $1.38M as of Q2 2026.
- ARS Investment Partners left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.06% of ARS Investment Partners's portfolio in Q2 2026, its #95 holding.
- ARS Investment Partners first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
- ARS Investment Partners's Thermo Fisher Scientific position peaked at $7.19M in Q3 2016.
- 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.